Research Progress on the Mechanism of Lipocalin-2 in Neurological Diseases

Lipocalin-2 (LCN2), a member of the human lipocalin family, has been demonstrated to be closely associated with diabetes, cardiovascular diseases, and renal disorders. Recent studies have indicated that LCN2 plays a significant regulatory role in the pathogenesis and progression of various neurologi...

Full description

Saved in:
Bibliographic Details
Main Authors: ZHOU Yongtai, YANG Zhenyu, LI Yan, WU Jiajing, ZHAO Bo
Format: Article
Language:zho
Published: Editorial Office of Medical Journal of Peking Union Medical College Hospital 2025-03-01
Series:Xiehe Yixue Zazhi
Subjects:
Online Access:https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2025-0028
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850187584752320512
author ZHOU Yongtai
YANG Zhenyu
LI Yan
WU Jiajing
ZHAO Bo
author_facet ZHOU Yongtai
YANG Zhenyu
LI Yan
WU Jiajing
ZHAO Bo
author_sort ZHOU Yongtai
collection DOAJ
description Lipocalin-2 (LCN2), a member of the human lipocalin family, has been demonstrated to be closely associated with diabetes, cardiovascular diseases, and renal disorders. Recent studies have indicated that LCN2 plays a significant regulatory role in the pathogenesis and progression of various neurological diseases by mediating pathways such as inflammation, oxidative stress, and ferroptosis. This article reviews the research advancements on the mechanism of LCN2 in neurological disorders, including cerebrovascular diseases, cognitive impairment disorders, Parkinson's disease, depression, and anxiety disorders, aiming to enhance clinical understanding.
format Article
id doaj-art-bb0ae5e333c44927b6a1bf1cbf68a526
institution OA Journals
issn 1674-9081
language zho
publishDate 2025-03-01
publisher Editorial Office of Medical Journal of Peking Union Medical College Hospital
record_format Article
series Xiehe Yixue Zazhi
spelling doaj-art-bb0ae5e333c44927b6a1bf1cbf68a5262025-08-20T02:16:05ZzhoEditorial Office of Medical Journal of Peking Union Medical College HospitalXiehe Yixue Zazhi1674-90812025-03-0116233033710.12290/xhyxzz.2025-0028Research Progress on the Mechanism of Lipocalin-2 in Neurological DiseasesZHOU YongtaiYANG ZhenyuLI YanWU JiajingZHAO Bo0Department of Neurology, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou 730050, ChinaLipocalin-2 (LCN2), a member of the human lipocalin family, has been demonstrated to be closely associated with diabetes, cardiovascular diseases, and renal disorders. Recent studies have indicated that LCN2 plays a significant regulatory role in the pathogenesis and progression of various neurological diseases by mediating pathways such as inflammation, oxidative stress, and ferroptosis. This article reviews the research advancements on the mechanism of LCN2 in neurological disorders, including cerebrovascular diseases, cognitive impairment disorders, Parkinson's disease, depression, and anxiety disorders, aiming to enhance clinical understanding.https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2025-0028lipocalin-2cerebrovascular diseasecognitive impairment diseasesneurodegenerative diseaseanxiety disordersdepression
spellingShingle ZHOU Yongtai
YANG Zhenyu
LI Yan
WU Jiajing
ZHAO Bo
Research Progress on the Mechanism of Lipocalin-2 in Neurological Diseases
Xiehe Yixue Zazhi
lipocalin-2
cerebrovascular disease
cognitive impairment diseases
neurodegenerative disease
anxiety disorders
depression
title Research Progress on the Mechanism of Lipocalin-2 in Neurological Diseases
title_full Research Progress on the Mechanism of Lipocalin-2 in Neurological Diseases
title_fullStr Research Progress on the Mechanism of Lipocalin-2 in Neurological Diseases
title_full_unstemmed Research Progress on the Mechanism of Lipocalin-2 in Neurological Diseases
title_short Research Progress on the Mechanism of Lipocalin-2 in Neurological Diseases
title_sort research progress on the mechanism of lipocalin 2 in neurological diseases
topic lipocalin-2
cerebrovascular disease
cognitive impairment diseases
neurodegenerative disease
anxiety disorders
depression
url https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2025-0028
work_keys_str_mv AT zhouyongtai researchprogressonthemechanismoflipocalin2inneurologicaldiseases
AT yangzhenyu researchprogressonthemechanismoflipocalin2inneurologicaldiseases
AT liyan researchprogressonthemechanismoflipocalin2inneurologicaldiseases
AT wujiajing researchprogressonthemechanismoflipocalin2inneurologicaldiseases
AT zhaobo researchprogressonthemechanismoflipocalin2inneurologicaldiseases